Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson's Disease
Gain Therapeutics, Inc.新药GT-02287作用机制 - GT-02287与内质网中的葡萄糖苷酶(GCase)相互作用，帮助正确折叠GCase[1] - 防止GCase酶突变的内质网滞留、内质网应激和相关降解[2] - 增强溶酶体活性和高效处理GCase底物葡糖鞘氨醇[3]